Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: Report from the Turkish SENTRY Program sites

Journal of Medical Microbiology

Volumn 57, Issue 12, 2008, Pages 1529-1532

  Gur, Deniz ^a   Korten, Volken ^b   Unal, Serhat ^a   Deshpande, Lalitagauri M ^c   Castanheira, Mariana ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BACTERIAL ENZYME; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXA 23; OXA 58; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL VARIATION; CLONE; ENZYME SYNTHESIS; HOSPITAL; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TURKEY (REPUBLIC);

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; EPIDEMIOLOGY, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; SENTINEL SURVEILLANCE; TURKEY;

EID: 57749208181     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/002469-0     Document Type: Article

References (12)

1. Alp, E., Esel, D., Yildiz, O., Voss, A., Melchers, W. & Doganay, M. (2006). Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital. Scand J Infect Dis 38, 335-340.
2. Brown, S. & Amyes, S. (2006). OXA β-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 57, 1-3.
3. CLSI (2006). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th edn. Approved standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
4. CLSI (2008). Performance Standards for Antimicrobial Susceptibility Testing; 18th informational supplement, M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
5. OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 51, 1530-1533.
6. Marque, S., Poirel, L., Heritier, C., Brisse, S., Blasco, M. D., Filip, R., Coman, G., Naas, T. & Nordmann, P. (2005). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 43, 4885-4888.
7. Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N. & Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3471-3484.
8. Poirel, L. & Nordmann, P. (2006). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12, 826-836.
9. Poirel, L., Pitout, J. D. & Nordmann, P. (2007). Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2, 501-512.
10. OXA-23 from Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3040-3041.
11. Vahaboglu, H., Budak, F., Kasap, M., Gacar, G., Torol, S., Karadenizli, A., Kolayli, F. & Eroglu, C. (2006). High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 58, 537-542.
12. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351-353.